Powered 500 · 2026POWEREDS. 116 of 500
By founding August Bioservices in 2020 and driving a $64.7 million Nashville expansion, Jenn Adams is building specialized sterile injectable manufacturing capacity at a moment when domestic pharmaceutical supply chains are under intense scrutiny.
Jenn Adams founded August Bioservices in 2020, a Nashville-based contract development and manufacturing organization specializing in sterile injectables.
Before launching August, she served as SVP and President of AmerisourceBergen's Clinical Product Solutions business and held senior roles at Baxter Healthcare. In 2025 she continued a $64.7 million Nashville expansion, adding sterile manufacturing capacity.
Interview · In Pipeline
Sponsored placement
An invitation, extended to Powered readers.
Drive the Continental GT S.
Request a test driveBentley T&Cs apply
